Detection of generated free radicals, lipid peroxidation and some trace elements status in Egyptian patients with chronic hepatitis C.
DOI:
https://doi.org/10.48165/Keywords:
Chronic hepatitis C, oxidative stress, Trace elements, Ca, iCaAbstract
Hepatitis C virus (HCV) is the etiological agent accounting for chronic liver disease in approximately 2–3% of the population worldwide. In Egypt, HCV infection has become one of the national health problems. The aim of the suggested study was to investigate if any correlation exists between total free radicals generated in chronic hepatitis C patients and some trace elements in blood and urine. The study included 104 subjects, 22 healthy controls and 82 CHC patients grouped as follows: Gr I (control group), Gr II [compensated chronic liver disease (without cirrhosis)], Gr III [decompensated liver cirrhosis (with cirrhosis)] and Gr IV [(hepatocellular failure (end stage liver disease)].Correlations of total free radicals and malondialdehyde )MDA( with other trace elements were studied in different groups. Blood and urinary trace elements concentrations varied among the different stages of HCV patients studied groups. The correlation coefficient between the different variables independently changed. Results of the present study revealed that total free radicals, MDA, blood copper (Cu), urinary zinc (Zn) as well as the total calcium (Ca) and ionized calcium (iCa) concentrations were significantly increased in all CHC patients groups, while blood Zinc (Zn) and selenium (Se) concentrations were significantly decreased in all CHC patients groups compared to those of control group.The urinary cupper (Cu) concentration was significantly elevated only in Gr II. Gr III and Gr IV showed significant low values of blood iron (Fe). Conclusion: blood and urinary trace elements profile was suggested to be a good indicator for assessing liver damage in chronic HCV patients. Oxidative stress with subsequent increase or decrease in blood and urinary trace elements in hepatitis C infected individuals could happen at various stages of liver damage causing impairment in the levels of measured trace elements. The correlation between trace elements and either total free radicals or MDA showed different pattern according to the stage of the disease.
References
Aaseth, J.; Ringstad, J.; Bell, H. and Thomassen, Y. (1990): Alcohol, Trace Elements, and liver dysfunction. In: Trace Elements in Clinical Medicine, Tomita, H. (Ed.), Springer-Verlag, Tokyo, pp. 79.
Abdalla, M.Y.; Ahmad, I.M.; Spitz, D.R.; Schmidt, W.N. and Britigan, B.E. (2005): Hepatitis C virus-core and non-structural proteins lead to different effects on cellular antioxidant defenses. J. Med. Virol., 76(4): 489.
Arciello, M.; Gori, M. and Balsano, C. (2013): Mitochondrial Dysfunctions and Altered Metals Homeostasis: New Weapons to Counteract HCV-Related Oxidative Stress. Oxid. Med. Cell. Longev., Article ID 971024. doi: 10.1155/2013/971024.
Attia, H.A.M.; Zekri, A.N.; Goudsmit, J.; Boom, R.; Khaled, H.M.; Mansour, M.T.; Dewaf, F.; Alam El-Din, H.M. and Sol, C.J.A. (1996): Diverse Patterns of Recognition of Hepatitis C Core and Non-Structural Antigens by Antibodies Present in Egypt Cancer Patients and Blood Donors. J. Clin. Microbiol., 34(11): 2665.
Bergqvist, A.; Sundstrom, S.; Dimberg, L.Y.; Gylfe, E. and Masucci, M.G. (2003): The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations. J. Biol. Chem., 278(21): 18877.
Boffi, F.M.; Ozaki, J.; Matsuki, N.; Inaba, M.; Desmaras, E. and Ono, K. (2002): Effects of Chemical Ischemia on Purine Nucleotides, Free Radical Generation, Lipids Peroxidation and Intracellular Calcium Levels in C2C12 Myotube Derived from Mouse Myocytes. J. Vet. Med. Sci., 64(6): 483.
Bourre, J.M. (2006): Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 1: Micronutrients. J. Nutr. Health Aging., 10(5): 377.
Bygrave, F.L. and Benedetti, A. (1993): Calcium: Its modulation in liver by cross-talk between the actions of glucagon and calcium-mobilizing agonists. Biochem. J., 296: 1.
Carlo, C.; Daniela, P. and Giancarlo, C. (2003): Iron depletion and response to interferon in chronic hepatitis C. Hepatogastroenterology, 50: 1467.
Carlson, B.A.; Novoselov, S.V.; Kumaraswamy, E.; Lee, B.J.; Anver, M.R.; Gladyshev, V.N. and Hatfield, D.L. (2004): Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J. Biol. Chem., 279(9): 8011.
Choi, J. and Ou, J.H. (2006): Mechanisms of Liver Injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am. J. Physiol. Gastrointest. Liver Physiol., 290(5): G847.
Choi, J.; Lee, K.J.; Zheng, Y.; Yamaga, A.K.; Lai, M.M. and Ou, J.H. (2004): Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology, 39(1): 81.
Ciccaglione, A.R.; Costantino, A.; Tritarelli, E.; Marcantonio, C.; Equestre, M.; Marziliano, N. and Rapicetta, M. (2005): Activation of endoplasmic reticulum stress response by hepatitis C virus proteins. Arch. Virol., 150(7): 1339.
Contreras-Zentella, M.L. and Hernández-Muñoz, R. (2016): Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress? Oxid. Med. Cell Longev., 2016, Article ID 3529149. doi: 10.1155/2016/3529149.
Corrocher, R.; Casaril, M.; Bellisola, G.; Gabrielli, G.B.; Nicoli, N.; Guidi, G.C. and De Sandre, G. (1986): Severe impairment of antioxidant system in human hepatoma. Cancer, 58(8): 1658.
Cunningham-Rumdles, S.; Ahrn, S.; Abuav-Nussbaum, R. and Dnistrian, A. (2002): Development of immunocompetence: Role of micronutrients and microorganisms. Nutr. Rev., 60: S68.
Czuczejko, J.; Zachara, B.A.; Staubach-Topczewska, E.; Halota, W. and Kedziora, J. (2003): Selenium, glutathione and glutathione peroxidase in blood of patients with chronic liver diseases. Acta Biochim. Polon., 50: 1147.
Dhawan, D. and Goel, A. (1996): Further evidence for zinc as a hepatoprotective agent in rat liver toxicity. Exp. Mol. Pathol., 63: 110.
Di Bona, D.; Cippitelli, M.; Fionda, C.; Camma, C.; Licata, A.; Santoni, A. and Craxi, A. (2006): Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J. Hepatol., 45(2): 271.
Ebara, M.; Fukuda, H.; Hatano, R.; Yoshikawa, M.; Sugiura, N.; Saisho, H.; Kondo, F. and Yukawa, M. (2003): Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus. Reference to hepatocellular carcinoma. Oncology, 65(4): 323.
Fisher, A.E. and Naughton, D.P. (2003): Vitamin C contributes to inflammation via radical generating mechanisms: A cautionary note. Med. Hypotheses, 61: 657.
Frank, C.; Mohamed, M.K.; Strickland, G.T.; Lavanchy, D.; Arthur, R.R.; Magder, L.S.; El Khoby, T.; Abdel-Wahab, Y.; AlyOhn, E.S.; Anwar, W., et al. (2000): The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355(9207): 887.
Ganz, T. and Nemeth, E. (2012): Hepcidin and iron homeostasis. Biochim. Biophys. Acta, 1823(9): 1434.
Gattoni, A.; Parlato, A.; Vangieri, B.; Bresciani, M.; Derna, R. and Baldassarre, R. (2006): Role of hemochromatosis genes in chronic hepatitis C. Clin. Ter., 157(1): 61.
Gladyshev, V.N.; Stadtman, T.C.; Hatfield, D.L. and Jeang, K. (1999): Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc. Natl. Acad. Sci. USA, 96: 835.
Gohn, A. (1986): ESR and Elementary Particle Applications. John Wiley, New York.
Gong, G.; Waris, G.; Tanveer, R. and Siddiqui, A. (2001): Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc. Natl. Acad. Sci. USA, 98: 9599.
Gonzalez-Calvin, J.L.; Garcia-Sanchez, A.; Bellot, V.; Munoz-Torres, M.; Raya-Alvarez, E. and Salvatierra-Rios, D. (1993): Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol., 28(5): 571.
Heckly, R.J. (1972): Free radicals in dry tissues. In: Swartz, H.M.; Bolton, J.R. and Borg, D.C. (Eds.), Biological Applications of Electron Spin Resonance. Wiley-Interscience, John Wiley & Sons, New York.
Heckly, R.J. (1976): Free Radicals in Dry Biological Systems. In: Pryor, W.A. (Ed.), Free Radicals in Biology, Volume II. Academic Press, New York.
Hiraga, N.; Suzuki, F.; Akuta, N.; Suzuki, Y.; Sezaki, H.; Hosaka, T.; Someya, T.; Kobayashi, M.; Saitoh, S.; Arase, Y.; Ikeda, K.; Kobayashi, M.; Matsuda, M.; Watabiki, S.; Satoh, J. and Kumada, H. (2005): Clinical and Virological Characteristics of Untreated Patients With Chronic Hepatitis C Who Develop Serum Alanine Aminotransferase Flare-up. J. Med. Virol., 75: 240.
Huang, M.L.H.; Lane, D.J.R. and Richardson, D.R. (2011): Mitochondrial mayhem: The mitochondrion as a modulator of iron metabolism and its role in disease. Antioxid. Redox Signal., 15(12): 3003.
Ioannou, G.N.; Dominitz, J.A.; Weiss, N.S.; Heagerty, P.J. and Kowdley, K.V. (2003): Differences in the relationship between hepatitis C infection and iron stores. Hepatology, 37(4): 795.
Ivanov, A.V.; Bartosch, B.; Smirnova, O.A.; Isaguliants, M.G. and Kochetkov, S.N. (2013): HCV and Oxidative Stress in the Liver. Viruses, 5(2): 439.
Jain, S.K.; Pemberton, P.W.; Smith, A.; McMahon, R.F.; Burrows, P.C.; Aboutwerat, A. and Warnes, T.W. (2002): Oxidative stress in chronic hepatitis C: Not just a feature of late stage disease. J. Hepatol., 36: 805.
Kalkan, A.; Bulut, V.; Avci, S.; Celik, I. and Bingol, N.K. (2002): Trace elements in viral hepatitis. J. Trace Elem. Med. Biol., 16(4): 227.
Kamochi, M.; Aibara, K.; Nakata, K.; Murakami, M.; Nandate, K.; Sakamoto, H.; Sata, T. and Shigematsu, A. (2002): Profound ionized hypomagnesemia induced by therapeutic plasma exchange in liver failure patients. Transfusion, 42(12): 1598.
Klein, D.; Lichtmannegger, J.; Finckh, M. and Summer, K.H. (2003): Gene expression in the liver of Long-Evans cinnamon rats during the development of hepatitis. Arch. Toxicol., 77: 568.
Ko, W.; Guo, C.; Yeh, M.; Lin, L.; Hsu, G.W.; Chen, P.; Luo, M. and Lin, C. (2005): Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J. Gastroenterol., 11(30): 4697.
Kohchi, C.; Inagawa, H.; Nishizawa, T. and Soma, G. (2009): ROS and innate immunity. Anticancer Res., 29: 817.
Koivisto, M.; Valta, P.; Hockerstedt, K. and Lindgren, L. (2002): Magnesium depletion in chronic terminal liver cirrhosis. Clin. Transplant., 16(5): 325.
Kolachi, N.F.; Kazi, T.G.; Afridi, H.I.; Kazi, N.; Kandhro, G.A.; Shah, A.Q.; Baig, J.A.; Wadhwa, S.K.; Khan, S.; Shah, F.; Jamali, M.K. and Balal, M. (2011): Distribution of Copper, Iron, and Zinc in Biological Samples (Scalp Hair, Serum, Blood, and Urine) of Pakistani Viral Hepatitis (A–E) Patients and Controls. Biol. Trace Elem. Res., 143: 116.
Korenaga, M.; Okuda, M.; Otani, K.; Wang, T.; Li, Y. and Weinman, S.A. (2005a): Mitochondrial dysfunction in hepatitis C. J. Clin. Gastroenterol., 39(4 Suppl. 2): S162.
Korenaga, M.; Wang, T.; Li, Y.; Showalter, L.A.; Chan, T.; Sun, J. and Weinman, S.A. (2005b): Hepatitis C Virus Core Protein Inhibits Mitochondrial Electron Transport and Increases Reactive Oxygen Species (ROS) Production. J. Biol. Chem., 280(45): 37481.
Kuchay, M.S.; Mishra, S.K.; Farooqui, K.J.; Bansal, B.; Wasir, J.S. and Mithal, A. (2016): Hypercalcemia of advanced chronic liver disease: A forgotten clinical entity. Clin. Cases Miner. Bone. Metab., 13(1): 15.
Leary, S.C. (2010): Redox regulation of SCO protein function: Controlling copper at a mitochondrial crossroad. Antioxid. Redox Signal., 13(9): 1403.
Li, S.; Tan, H.; Wang, N.; Zhang, Z.; Lao, L.; Wong, C. and Feng, Y. (2015): The Role of Oxidative Stress and Antioxidants in Liver Diseases. Int. J. Mol. Sci., 16: 26087.
Lin, C.C.; Huang, J.F.; Tsai, L.Y. and Huang, Y.L. (2006): Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol. Trace Elem. Res., 109(1): 15.
Loguercio, C. and Federico, A. (2003): Oxidative stress in viral and alcoholic hepatitis. Free Radic. Biol. Med., 34(1): 1.
Loguercio, C.; De Girolamo, V.; Federico, A.; Feng, S.L.; Crafa, E.; Cataldi, V.; Gialanella, G.; Moro, R. and Del Vecchio, B.C. (2001): Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol. Trace Elem. Res., 81: 245.
Mansurova, F.Kh.; Mutikhova, Kh.Sh. and Olimova, S.O. (2005): Lipid peroxidation and antioxidative protection in patients with chronic type C hepatitis. Klin. Med. (Mosk), 83(5): 39.
Marchesini, G.; Fabbri, A.; Bianchi, G.; Brizi, M. and Zoli, M. (1996): Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology, 23(5): 1084.
Mattie, M.D. and Freedman, J.H. (2004): Copper-inducible transcription: Regulation by metal- and oxidative stress-responsive pathways. Am. J. Physiol. Cell Physiol., 286(2): C293.
McClain, C.J.; Adams, L. and Shedlofsky, S. (1988): Zinc and the gastrointestinal system. In: Prasad, A.S. (Ed.), Essential and Toxic Elements in Health and Disease. Liss, New York, pp. 55.
Melhem, A.; Stern, M.; Shibolet, O.; Israeli, E.; Ackerman, Z.; Pappo, O.; Hemed, N.; Rowe, M.; Ohana, H.; Zabrecky, G.; Cohen, R. and Ilan, Y. (2005): Treatment of chronic hepatitis C virus infection via antioxidants: Results of a phase I clinical trial. J. Clin. Gastroenterol., 39(8): 737.
Meran, L.; Sirmatel, F.; Ahi, S. and Tarakcioglu, M. (2004): Plasma copper and zinc levels in chronic viral hepatitis. Saudi Med. J., 25(8): 1066.
Metwally, M.A.; Zein, C.O. and Zein, N.N. (2004): Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am. J. Gastroenterol., 99: 286.
Milton, J.S.; Corbert, J.J. and McTeer, P.M. (1986): Introduction to Statistics (3rd ed.). D.C. Heath and Company, Canada.
Miyamoto, Y.; Koh, Y.H.; Park, Y.S.; Fujiwara, N.; Sakiyama, H.; Misonou, Y.; Ookawara, T.; Suzuki, K.; Honke, K. and Taniguchi, N. (2003): Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol. Chem., 384(4): 567.
Mohammed, M.A.; AbdElmaksouda, M.D.; Abd El Maksouda, N.; El-Mezayenb, H.A. and El-Garaamc, H. (2012): Serum levels of trace elements in Egyptian patients with chronic hepatitis C under interferon therapy. J. Gene. Eng. Biotechnol., 10: 81.
Mohammed, N.; Abbasi, M.S.; Hasani, S.R.; Mohebi, M.R. and Zali, J. (2010): Serum levels of trace elements in Egyptian patients with chronic hepatitis C under interferon therapy. Hepatitis, 10: 62.
Morbitzer, M. and Herget, T. (2005): Expression of Gastrointestinal Glutathione Peroxidase Is Inversely Correlated to the Presence of Hepatitis C Virus Subgenomic RNA in Human Liver Cells. J. Biol. Chem., 280(10): 8831.
Mottaran, E.; Stewart, S.F.; Rolla, R.; Vay, D.; Cipriani, V.; Moretti, M.; Vidali, M.; Sartori, M.; Rigamonti, C.; Day, C.P. and Albano, E. (2002): Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic. Biol. Med., 32(1): 38.
Nagamine, T.; Takagi, H.; Hashimoto, Y.; Takayama, H.; Shimoda, R.; Nomura, N.; Suzuki, K.; Mori, M. and Nakajima, K. (1997): The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients. Biol. Trace Elem. Res., 58: 65.
Nagoev, B.S.; Abidov, M.T. and Ivanova, M.R. (2002): LPO and free-radical oxidation parameters in patients with acute viral hepatitis. Bull. Exp. Biol. Med., 134(6): 557.
Nandi, S.S.; Chawla, Y.K.; Nath, R. and Dilawari, J.B. (1989): Serum and urinary zinc in fulminant hepatic failure. J. Gastroenterol. Hepatol., 4(3): 209.
Nazir, F.; Sarfraz, A.R.; Qudoos, A. and Riaz, R. (2013): Trace Elements Profile of Hepatitis C Patients in Faisalabad, Pakistan. WASJ, 28(8): 1093.
Nicotera, P.; Hartzell, P.; Baldi, C.; Svensson, S.A.; Bellomo, G. and Orrenius, S. (1986): Cystamine induces toxicity in hepatocytes through the elevation of cytosolic Ca2+ and the stimulation of a nonlysosomal proteolytic system. J. Biol. Chem., 261(31): 14628.
Nozic, D.; Balint, B.; Stankovic, N.; Dimitrijevic, J. and Neskovic, G. (2005): Significance of iron reduction for the therapy of chronic hepatitis C. Vojnosanit Pregl., 62(2): 161.
Pantopoulos, K.; Porwal, S.K.; Tartakoff, A. and Devireddy, L. (2012): Mechanisms of mammalian iron homeostasis. Biochemistry, 51(29): 5705.
Paracha, U.Z.; Kaneez, F.; Alqahtani, M.; Adeel, C.; Abuzenadah, A.; Damanhouri, G. and Qadri, I. (2013): Oxidative stress and hepatitis C virus. Virology, 10: 251.
Parola, M. and Robino, G. (2001): Oxidative stress related molecules and liver fibrosis. J. Hepatol., 35: 297.
Pascual, E.C.; Goodman, B.A. and Yeretzian, C. (2002): Characterization of free radicals in soluble coffee by electron paramagnetic resonance spectroscopy. J. Agric. Food Chem., 50(21): 6114.
Rashed, M.N. (2011): The role of trace elements on hepatitis virus infections: A review. J. Trace Elem. Med. Biol., 25: 181.
Razzaq, Z. and Malik, A. (2014): Viral load is associated with abnormal serum levels of micronutrients and glutathione and glutathione-dependent enzymes in genotype 3 HCV patients. BBA Clin., 2: 72–78.
Rocchi, E.; Borella, P.; Borghi, A.; Paolillo, F.; Pradelli, M.; Farina, F. and Casalgrandi, G. (1994): Zinc and magnesium in liver cirrhosis. Eur. J. Clin. Invest., 24(3): 149.
Romero, F.J.; Bosch-Morell, F.; Romero, M.J.; Jareño, E.J.; Romero, B.; Marín, N. and Romá, J. (1998): Lipid peroxidation products and antioxidants in human disease. Environ. Health Perspect., 106(5): 1229.
Ryter, S.W.; Kim, H.P.; Hoetzel, A.; Park, J.W.; Nakahira, K.; Wang, X. and Choi, A.M. (2007): Mechanisms of cell death in oxidative stress. Antioxid. Redox Signal., 9(1): 49.
Saad, E.A. (2014): Non-invasive Assessment of Liver Fibrosis Using Serum Markers. J. Pharm. Chem. Biol. Sci., 2(2): 59.
Saeian, K.; Bajaj, J.S.; Franco, J.; Knox, J.F.; Daniel, J.; Peine, M.D.; Varma, R.R. and Ho, S. (2004): High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin. Aliment Pharmacol. Ther., 20(10): 1189.
Sebastiani, G.; Vario, A.; Ferrari, A.; Pistis, R.; Noventa, F. and Alberti, A. (2006): Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. J. Viral Hepatitis, 13(3): 199.
Shan, Y.; Lambrecht, R.W. and Bonkovsky, H.L. (2005): Association of hepatitis C virus infection with serum iron status: Analysis of data from the third National Health and Nutrition Examination Survey. Clin. Infect. Dis., 40(6): 834.
Sikorska, K.; Stalke, P.; Lakomy, E.A.; Michalska, Z.; Witczak-Malinowska, K. and Stolarczyk, J. (2003): Disturbances of iron metabolism in chronic liver diseases. Med. Sci. Monit., 9(3): 64.
Sun, Y. (1990): Free radicals, anti-oxidant enzymes, and carcinogenesis. Free Radical Biol. Med., 8: 583.
Takagi, H.; Kakizaki, S.; Sohara, N.; Sato, K.; Tsukioka, G.; Tago, Y.; Konaka, K.; Kabeya, K.; Kaneko, M.; Takayama, H.; Hashimoto, Y.; Yamada, T.; Takahashi, H.; Shimojo, H.; Nagamine, T. and Mori, M. (2003): Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis. Int. J. Vitam. Nutr. Res., 73(6): 411.
Tardif, K.D.; Waris, G. and Siddiqui, A. (2005): Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol., 13(4): 159.
Taylor, E.R.; Hurrell, F.; Shannon, R.J.; Lin, T.K.; Hirst, J. and Murphy, M.P. (2003): Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J. Biol. Chem., 278(22): 19603.
Thuluvath, P.J. and Triger, D.R. (1992): Selenium in chronic liver disease. J. Hepatol., 14(2–3): 176.
Vendemiale, G.; Grattagliano, I.; Portincasa, P.; Serviddio, G.; Palasciamo, G. and Altomare, E. (2001): Oxidative stress in symptom-free HCV carriers: Relation with ALT flare-up. Eur. J. Clin. Invest., 31: 54.
Wang, J.; Holmes, T.H.; Cheung, R.; Greenberg, H.B. and He, X.S. (2004): Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: Its relationship to liver inflammation. J. Infect. Dis., 190(5): 989.
Wang, T. and Weinman, S.A. (2006): Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J. Gastroenterol. Hepatol., 21(3): S34.
Weinreb, O.; Amit, T.; Mandel, S.; Kupershmidt, L. and Youdim, M.B. (2010): Neuroprotective multifunctional iron chelators: From redox-sensitive process to novel therapeutic opportunities. Antioxid. Redox Signal., 13(6): 919.
West, A.P.; Shadel, G.S. and Ghosh, S. (2011): Mitochondria in innate immune responses. Nat. Rev. Immunol., 11: 389.
Yamaguchi, A.; Tazuma, S.; Nishioka, T.; Ohiishi, W.; Hyogo, H.; Nomura, S. and Chayama, K. (2005): Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig. Dis. Sci., 50(7): 1361.
Yano, M.; Hayashi, H.; Yoshioka, K.; Kohgo, Y.; Saito, H.; Niitsu, Y.; Kato, J.; Iino, S.; Yotsuyanagi, H.; Kobayashi, Y.; Kawamura, K.; Kakumu, S.; Kaito, M.; Ikoma, J.; Wakusawa, S.; Okanoue, T.; Sumida, Y.; Kimura, F.; Kajiwara, E.; Sata, M. and Ogata, K. (2004): A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: A multicenter, prospective, randomized, controlled trial in Japan. J. Gastroenterol., 39(6): 570.
Yoshioka, T.; Kawada, K.; Shimada, T. and Mori, M. (1979): Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am. J. Obstet. Gynecol., 135(3): 372.
Zhang, W.; Ramanathan, C.S.; Nadimpalli, R.G.; Bhat, A.A.; Cox, A.G. and Taylor, E.W. (1999): Selenium-dependent glutathione peroxidase modules encoded by RNA viruses. Biol. Trace Elem. Res., 70(2): 97.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
